ZA201002218B - Thiadiazinone derivatives - Google Patents

Thiadiazinone derivatives

Info

Publication number
ZA201002218B
ZA201002218B ZA2010/02218A ZA201002218A ZA201002218B ZA 201002218 B ZA201002218 B ZA 201002218B ZA 2010/02218 A ZA2010/02218 A ZA 2010/02218A ZA 201002218 A ZA201002218 A ZA 201002218A ZA 201002218 B ZA201002218 B ZA 201002218B
Authority
ZA
South Africa
Prior art keywords
thiadiazinone derivatives
thiadiazinone
derivatives
Prior art date
Application number
ZA2010/02218A
Other languages
English (en)
Inventor
Oliver Schadt
Dieter Dorsch
Frank Stieber
Andree Blaukat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA201002218B publication Critical patent/ZA201002218B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2010/02218A 2007-08-30 2010-03-29 Thiadiazinone derivatives ZA201002218B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007041115A DE102007041115A1 (de) 2007-08-30 2007-08-30 Thiadiazinonderivate
PCT/EP2008/006466 WO2009030333A1 (de) 2007-08-30 2008-08-06 Thiadiazinonderivate

Publications (1)

Publication Number Publication Date
ZA201002218B true ZA201002218B (en) 2010-12-29

Family

ID=39952448

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/02218A ZA201002218B (en) 2007-08-30 2010-03-29 Thiadiazinone derivatives

Country Status (16)

Country Link
US (1) US8211886B2 (OSRAM)
EP (1) EP2181111B1 (OSRAM)
JP (1) JP5524840B2 (OSRAM)
KR (1) KR20100065171A (OSRAM)
CN (1) CN101784544B (OSRAM)
AR (1) AR068130A1 (OSRAM)
AU (1) AU2008295193B2 (OSRAM)
BR (1) BRPI0816058A2 (OSRAM)
CA (1) CA2698062C (OSRAM)
DE (1) DE102007041115A1 (OSRAM)
EA (1) EA017393B1 (OSRAM)
ES (1) ES2426356T3 (OSRAM)
IL (1) IL204127A (OSRAM)
MX (1) MX2010002096A (OSRAM)
WO (1) WO2009030333A1 (OSRAM)
ZA (1) ZA201002218B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012003338A1 (en) 2010-07-01 2012-01-05 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
EP3229836B1 (en) 2014-12-09 2019-11-13 Institut National de la Sante et de la Recherche Medicale (INSERM) Human monoclonal antibodies against axl
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795964A (en) 1980-12-04 1982-06-15 Morishita Seiyaku Kk Preparation of 2-substituted-3(2h)-pyridazinone derivative
US4397854A (en) 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
DE4310699A1 (de) 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone
IL115889A0 (en) 1994-11-14 1996-01-31 Rohm & Haas Pyridazinones and their use as fungicides
US5635494A (en) 1995-04-21 1997-06-03 Rohm And Haas Company Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
DE19604388A1 (de) 1996-02-07 1997-08-14 Merck Patent Gmbh Arylalkyl-diazinone
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
DE69709319T2 (de) 1996-03-05 2002-08-14 Astrazeneca Ab, Soedertaelje 4-anilinochinazolin derivate
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
RU2209813C2 (ru) 1997-11-19 2003-08-10 Кова Ко., Лтд. Производные пиридазина, лекарственные средства на их основе и способ лечения артрита
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
CN1431999A (zh) 2000-05-31 2003-07-23 阿斯特拉曾尼卡有限公司 具有血管损伤活性的吲哚衍生物
RU2003103603A (ru) 2000-07-07 2004-08-20 Энджиоджен Фармасьютикалз Лимитед (Gb) Производные колхинола в качестве ингибиторов ангиогенеза
JP2004502766A (ja) 2000-07-07 2004-01-29 アンギオジェン・ファーマシューティカルズ・リミテッド 血管損傷剤としてのコルヒノール誘導体
CZ2004516A3 (cs) 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
DE102005055355A1 (de) 2005-11-21 2007-10-31 Merck Patent Gmbh 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate
DE102005055354A1 (de) 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
DE102006037478A1 (de) * 2006-08-10 2008-02-14 Merck Patent Gmbh 2-(Heterocyclylbenzyl)-pyridazinonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate

Also Published As

Publication number Publication date
CN101784544A (zh) 2010-07-21
ES2426356T3 (es) 2013-10-22
AU2008295193B2 (en) 2013-04-18
EA017393B1 (ru) 2012-12-28
EA201000364A1 (ru) 2010-08-30
US20100311733A1 (en) 2010-12-09
HK1146276A1 (en) 2011-05-20
IL204127A (en) 2013-08-29
JP2010536896A (ja) 2010-12-02
KR20100065171A (ko) 2010-06-15
WO2009030333A1 (de) 2009-03-12
DE102007041115A1 (de) 2009-03-05
MX2010002096A (es) 2010-03-26
CA2698062A1 (en) 2009-03-12
EP2181111B1 (de) 2013-06-26
AR068130A1 (es) 2009-11-04
CA2698062C (en) 2016-05-31
JP5524840B2 (ja) 2014-06-18
BRPI0816058A2 (pt) 2015-03-31
AU2008295193A1 (en) 2009-03-12
EP2181111A1 (de) 2010-05-05
CN101784544B (zh) 2012-08-29
US8211886B2 (en) 2012-07-03

Similar Documents

Publication Publication Date Title
HUS2400041I1 (hu) 4-Pirimidin-szulfamid-származék
ZA201003631B (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
IL202020A0 (en) Spiroindolinone derivatives
ZA201000431B (en) Indazolamide derivatives
ZA201001058B (en) Quinazolinamide derivatives
ZA200908298B (en) Bicycloaniline derivative
IL210548A0 (en) Spiroaminodihydrothiazine derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
PL2308877T3 (pl) Pochodne imidazopirydyn-2-onu
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
IL210406A0 (en) Pyrrolopyridinylpyrimidin - 2 - ylamine derivatives
IL210869A0 (en) Imidazothiadiazoles derivatives
IL208336A0 (en) Pyrisazinone derivatives
IL202667A0 (en) Isoxazole-imidazole derivatives
IL210164A0 (en) Thiazolylpiperidine derivatives
IL208548A0 (en) 2-phenyl-4-cyclopropyl-pyrimidine derivatives
EP2163554A4 (en) PYRIMIDODIAZEPINONE DERIVATIVE
PL2245028T3 (pl) Pochodne 5-aminocyklilometyloksazolidyn-2-onu
EP2133347A4 (en) 1-BIARYLAZETIDINONDERIVATE
IL202463A0 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
EP2228362A4 (en) 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE
ZA201002218B (en) Thiadiazinone derivatives
IL213051A0 (en) Difluorophenyldiacylhydrazide derivatives